News

Wegovy maker Novo's profit warning triggers $70 billion share rout
Pedersen, Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) -Investors wiped $70 billion off Novo Nordisk's market value on ...
Devdiscourse3h
European Stocks Rise Amidst Profit Warning and Pharmaceutical Shake-up
European stocks closed on a positive note with financials and defense stocks leading, despite a significant drop in Danish ...
The Copenhagen Post8h
Novo Nordisk lowers its expectations for 2025
Novo Nordisk has lowered its expectations for how much it will grow in 2025. The Danish pharmaceutical company announced this in a statement on Tuesday, 29 July. For the first half of 2025, the ...
European stocks close up; Novo Nordisk logs its biggest daily drop on record
European stocks closed higher on Tuesday, buoyed by financials and defence stocks, though Danish stocks logged their biggest ...
Novo Nordisk shares fall as it slashes 2025 outlook amid US sales drag
Novo Nordisk falls as company slashes 2025 forecasts as US sales of Wegovy and Ozempic face headwinds from compounded drugs.
Novo lowers forecast as weight-loss drug sales fall short
Novo Nordisk A/S lowered its financial forecast in a surprise update that cited lagging sales of its weight-loss drug Wegovy, ...
The Manila Times9h
Novo Nordisk lowers sales and operating profit outlook for 2025
Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for the first six months of ...
Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge
Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...